157 related articles for article (PubMed ID: 8308765)
1. HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis--their relation to disease progression.
Eberhardt K; Grubb R; Johnson U; Pettersson H
J Rheumatol; 1993 Nov; 20(11):1825-9. PubMed ID: 8308765
[TBL] [Abstract][Full Text] [Related]
2. Gm allotypes and HLA in rheumatoid arthritis patients with circulating antibodies to native type II collagen.
Sanders PA; Grennan DM; Klimiuk PS; Clague RB; deLange GG; Collins I; Dyer PA
Ann Rheum Dis; 1987 May; 46(5):391-4. PubMed ID: 3496057
[TBL] [Abstract][Full Text] [Related]
3. Increased frequency of Gm(1,2;21) phenotype in HLA-DR4 positive seropositive rheumatoid arthritis.
Zarnowski H; Mierau R; Werdier D; Antons M; Genth E; Hartl PW
J Rheumatol; 1986 Oct; 13(5):858-63. PubMed ID: 3493344
[TBL] [Abstract][Full Text] [Related]
4. Alloimmunization to human immunoglobulin genetic markers is frequent in early rheumatoid arthritis.
Grubb R; Eberhardt K; Johnson U
Exp Clin Immunogenet; 1991; 8(4):219-26. PubMed ID: 1817565
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease.
Genth E; Zarnowski H; Mierau R; Wohltmann D; Hartl PW
Ann Rheum Dis; 1987 Mar; 46(3):189-96. PubMed ID: 2953314
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin allotypes in rheumatoid arthritis.
Sanders PA; Grennan DM
Exp Clin Immunogenet; 1989; 6(1):99-108. PubMed ID: 2698223
[TBL] [Abstract][Full Text] [Related]
7. Functional impairment and disability in early rheumatoid arthritis--development over 5 years.
Eberhardt KB; Fex E
J Rheumatol; 1995 Jun; 22(6):1037-42. PubMed ID: 7674227
[TBL] [Abstract][Full Text] [Related]
8. Extended haplotypes in rheumatoid arthritis and preliminary evidence for an interaction with immunoglobulin genes.
Puttick A; Briggs D; Welsh K; Jacoby R; Williamson E; Jones V
Dis Markers; 1986 Jun; 4(1-2):139-44. PubMed ID: 3482986
[TBL] [Abstract][Full Text] [Related]
9. Radiographic damage in large joints in early rheumatoid arthritis: relationship with radiographic damage in hands and feet, disease activity, and physical disability.
Kuper HH; van Leeuwen MA; van Riel PL; Prevoo ML; Houtman PM; Lolkema WF; van Rijswijk MH
Br J Rheumatol; 1997 Aug; 36(8):855-60. PubMed ID: 9291854
[TBL] [Abstract][Full Text] [Related]
10. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
Kaltenhäuser S; Wagner U; Schuster E; Wassmuth R; Arnold S; Seidel W; Tröltzsch M; Loeffler M; Häntzschel H
J Rheumatol; 2001 Apr; 28(4):735-44. PubMed ID: 11327243
[TBL] [Abstract][Full Text] [Related]
11. A comparison of clinical and immunogenetic features in familial and sporadic rheumatoid arthritis.
Sanders PA; Grennan DM; Dyer PA; Thomson W; deLange GG
J Rheumatol; 1987 Aug; 14(4):718-22. PubMed ID: 3499510
[TBL] [Abstract][Full Text] [Related]
12. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study.
Suarez-Almazor ME; Tao S; Moustarah F; Russell AS; Maksymowych W
J Rheumatol; 1995 Nov; 22(11):2027-33. PubMed ID: 8596139
[TBL] [Abstract][Full Text] [Related]
14. Relationship of progression of radiographic changes in hands and wrists, clinical features and HLA-DR antigens in rheumatoid arthritis.
Stockman A; Emery P; Doyle T; Hopper J; Tait B; Muirden K
J Rheumatol; 1991 Jul; 18(7):1001-7. PubMed ID: 1920304
[TBL] [Abstract][Full Text] [Related]
15. Reaction of rheumatoid factors with IgG3 monoclonal anti-Rh(D) antibodies: more frequent reactivity to a monoclonal antibody of the Gm allotype G3m(5) in rheumatoid patients negative for G3m(5).
Puttick AH; Williamson EA; Merry AH; Kumpel BM; Thompson KM; Jones VE
Ann Rheum Dis; 1988 Nov; 47(11):898-905. PubMed ID: 3207373
[TBL] [Abstract][Full Text] [Related]
16. Ig CH and D14S1 variants in rheumatoid arthritis--linkage and association studies.
Sidebottom D; Grennan DM; Green JR; Sanders PA; Ollier W; De Lange G
Br J Rheumatol; 1991 Jun; 30(3):167-72. PubMed ID: 1904786
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors in rheumatoid arthritis].
Rojkovich B; Poór G
Orv Hetil; 2002 Sep; 143(35):2019-26. PubMed ID: 12387195
[TBL] [Abstract][Full Text] [Related]
18. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis.
Rojas-Villarraga A; Diaz FJ; Calvo-Páramo E; Salazar JC; Iglesias-Gamarra A; Mantilla RD; Anaya JM
J Autoimmun; 2009 Feb; 32(1):64-9. PubMed ID: 19117726
[TBL] [Abstract][Full Text] [Related]
19. Incidence of severe outcome in rheumatoid arthritis during 20 years.
Jäntti JK; Kaarela K; Belt EA; Kautiainen HJ
J Rheumatol; 2002 Apr; 29(4):688-92. PubMed ID: 11950008
[TBL] [Abstract][Full Text] [Related]
20. HLA, C4, Bf, Gm and autoantibodies in rheumatoid arthritis.
Warlow RS; Uko G; Feeney DJ; Kay PH
Exp Clin Immunogenet; 1988; 5(2-3):133-42. PubMed ID: 3272816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
